Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 9, 2010
Pharmacy Choice - News - Generic Drugs - February 9, 2010

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 43     Next >>     Go To Page:

2/9/10 - Stock Hunter Has Breaking News!! Check This Alert Out!! ECOF "ECO2 Forests Projects Receives Vanuatu Government Approval":: Sign Up Today!!
Stock Hunter PRESENTS : Eco2 Forests Inc., SOHM, Inc., Blue Diamond Ventures, Inc., Technical Communications Corp. Avensys Corp., One World Ventures, Inc. www.Stockhunter.us. To sign up for our free Profiles & Alerts :: visit http://www.StockHunter.us. email us!!
2/9/10 - TheStockWizards.net: News and Technical Analysis Updates for February 9th 2010 OWVI, CBAI, GETA, SHMN, IMSC
Boca Raton FL, www.TheStockWizards.net a Premiere Financial Portal & Investor Relations Firm that brings a wealth of trading resources to Small Cap Investors, has compiled a list of stocks on the OTCBB, and Pink Sheet Markets that have positive technical indicators and may provide continued trading opportunities for investors.
2/8/10 - Lupin Receives FDA Approval for Amlodipine/Benazepril Capsules
BALTIMORE, Feb. 8Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for its Amlodipine/Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg and 10mg/20mg capsules. Lupin's Amlodipine/Benazepril capsules are the AB-rated generic equivalent of Novartis' Lotrel capsules indicated for the treatment
2/8/10 - NY S&P Healthcare
To: POLITICAL EDITORS.
2/8/10 - S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now?
NEW YORK, Feb. 8With the recent election of Senator Scott Brown in Massachusetts resulting in the loss of the Democratic supermajority, the urgency behind broad-based health care reform with the promise of universal coverage for the majority of uninsured Americans has faded dramatically, according to Standard & Poor's Equity Research.
2/8/10 - SHMN.PK Profiles for February 8, 2010
The team at Xtremepicks.com scans the US and Canadian markets looking for microcap companies which show promise and have unique niches and opportunities. Today's news alerts include: Press Release Source: SOHM, Inc. On Monday February 8, 2010, 8:30 am EST.
2/8/10 - Smokefree Innotec, Inc. & SOHM, Inc.
Boston, MA Smokefree Innotec, Inc.; SOHM, Inc. DayTradersDigest.com is part of Stock Profiler.US, LLC's News Division. Stock Profiler is pleased to introduce Smokefree Innotec, Inc. to the investment community. http://www.youtube.com/watch?v=SGVA7OcZNPU http://www.youtube.com/watch?v=LlTWQnMOoLY Please visit us at www.stockprofiler.us for more d
2/8/10 - SOHM India Enters High Growth Multi-Vitamin and Antioxidant Product Segment With Distribution in India and Emerging Target Markets
02/08/10 SOHM, Inc., a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that the Company has entered the multi-vitamin and antioxidant product segment in India and emerging target markets.
2/8/10 - SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products for Distribution Across India
02/08/10 SOHM, Inc., a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that is has signed a marketing agreement adding 75 branded generic pharmaceutical products for distribution across India. "Our India based production facility is generating unprecedented grow
2/8/10 - Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced that Steven Leventer, Ph.D. has been appointed Vice President, Clinical Research Neuroscience.
2/8/10 - Stock Hunter Is Hot!! Sign Up Today!! GETA,GOVX,NPWZ,VHGI,RDBO,SHMN
Stock Hunter PRESENTS : Genta Incorporated, GeoVax Labs, Inc., Neah Power Systems, Inc., VirtualHealth Technologies, Inc., Rodobo International, Inc., SOHM, Inc. www.Stockhunter.us. To sign up for our free Profiles & Alerts :: visit http://www.StockHunter.us. email us!!
2/8/10 - TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC REGIONS
02/08/10 Website: www.tevapharm.com www.activebiotech.com/ Contact: Elana Holzman Teva Pharmaceutical Industries Ltd. 972 926-7554 Kevin Mannix Teva North America 591-8912 Goran Forsberg Active Biotech AB +46 46-19 11 54. Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions.
2/8/10 - Tranzyme Pharma Announces Approval of Generic Name "Ulimorelin" for TZP-101, its First-in-Class Drug Candidate for the Treatment of Gastrointestinal...
Tranzyme Pharma Announces Approval of Generic Name "Ulimorelin" for TZP-101, its First-in-Class Drug Candidate for the Treatment of Gastrointestinal Dysmotility. Tranzyme Pharma announced that the United States Adopted Name Council has approved the generic name "ulimorelin" for Tranzyme's novel, late-stage, prokinetic agent TZP-101.
2/7/10 - Duke University publishes research in biopharmaceuticals
Data detailed in 'Statistical assessment of biosimilar products' have been presented. "Patents on the early biological products will soon expire in the next few years. The researchers concluded: "The possibility of using genomic data in evaluation of biosimilar products is also explored."
2/7/10 - Researchers from Duke University detail findings in drug development
New research, 'Statistical methods for assessment of biosimilarity using biomarker data,' is the subject of a report. "Food and Drug Administration indicated that the follow-on biologic products can be approved under an abbreviated new drug application if the innovator products are approved under a new drug application.
2/7/10 - Teva Announces Tentative Approval of Generic Femara(R) Tablets
Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application to market its generic version of Novartis' breast cancer treatment Femara Tablets, 2.5 mg. The brand product had annual sales of approximately $556 million in the United Stat
2/5/10 - More RandD cuts ahead for GSK [The News and Observer, Raleigh, N.C.]
Feb. 5GlaxoSmithKline, one of this region's largest private employers and the foundation of North Carolina's pharmaceutical industry, will continue to shrink. The British company that sells a wide range of products such as the Advair asthma treatment, weight-loss aid alli and Aquafresh toothpaste, is slashing costs as generic rivals hurt sales of
2/5/10 - Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits
Teva Pharmaceutical Industries Ltd. announced today that several of its subsidiaries in the United States reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, Inc. on behalf of the United States, Texas, Florida, and California under federal and state False Claims Acts.
2/5/10 - Teva Pharma settles some Medicaid drug price suits
NEW YORK Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, said Friday it is settling several lawsuits related to Medicaid reimbursement for its products, and is setting aside $315 million to cover the settlement and other suits. Teva did not say how much it will pay to resolve the lawsuits and how much will be placed i
2/5/10 - Teva to Donate Medicine to Haiti Earthquake Relief Effort
Teva Pharmaceutical Industries Ltd. announced that it will be donating over $7 million in medicine to benefit earthquake victims in Haiti. "As a company, Teva was devastated to hear about the earthquake and our hearts and thoughts go out to the country of Haiti," said Shlomo Yanai, Teva's President and Chief Executive Officer.
2/4/10 - Aspen and Lilly sign tuberculosis drug deal
Aspen Pharmacare, a South African generic pharmaceutical company, has entered into a $1 million agreement with Eli Lilly, a US-based pharmaceutical company, to develop generic versions of the Lilly's tuberculosis medicines, according to Reuters. As part of the agreement, Eli Lilly will transfer its drug production technology to Aspen.
2/4/10 - Hospira Reports Fourth-Quarter and Full-Year 2009 Results
LAKE FOREST, Ill., Feb. 4Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today reported results for the fourth quarter and full year ended Dec. 31, 2009. "Driven by double-digit revenue and adjusted earnings growth, the fourth quarter concluded a year of transformation for Hospira. Fourth-Quarter 2009 Resul
2/4/10 - SOHM Inc.: Grass Roots Research, Inc. Initiates Buy Recommendation Coverage With a Long-Term Target Price of $.41 per Share
02/04/10 SOHM, Inc., a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that Grass Roots Research and Distribution, Inc., a Wall Street leading independent research firm, has initiated unsolicited coverage on SOHM, Inc. with a "BUY" recommendation and a Long-Term
2/3/10 - Brazil Pharmaceuticals and Healthcare Report Q1 2010
Dublin - Research and Markets has announced the addition of the "Brazil Pharmaceuticals and Healthcare Report Q1 2010" report to their offering.
2/3/10 - Canada Pharmaceuticals and Healthcare Report Q1 2010
Dublin - Research and Markets. has announced the addition of the "Canada Pharmaceuticals and Healthcare Report Q1 2010" report to their offering.
Articles(s): 1 - 25 of 43     Next >>     Go To Page:


© 2010 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
An Overview of HIPAA for Healthcare Professionals
The Role of the Pharmacy Team in the Management of Hypertension
This lesson is supported by:
PharmaSmart
The Pharmacist's Role in Pain Management: A Legal Perspective
This lesson is supported by:
Purdue
Taking RAAS to a New Level-Direct Renin Inhibition and Novel Approaches to Combination Therapy
This lesson is supported by:
Novartis

Special Announcement

Free Membership
Click Here to register to Win an iPod nano.
Rules and Regulations
Enjoy Free CE, Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comRxTechSchool.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415